Background: To compare glycemic variability (GV) indices between patients with fibrocalculous pancreatic diabetes (FCPD) and type 2 diabetes mellitus (T2D) using continuous glucose monitoring (CGM).
Methods: We measured GV indices using CGM (iPro™2 Professional CGM, Medtronic, USA) data in 61 patients each with FCPD and T2D who were matched for glycated hemoglobin A1c (HbA1c) and duration of diabetes. GlyCulator2 software was used to estimate the CGM-derived measures of GV (SD, mean amplitude of glycemic excursion [MAGE], continuous overall net glycemic action [CONGA], absolute means of daily differences [MODD], M value, and coefficient of variance [%CV]), hypoglycemia (time spent below 70 mg/dL, AUC below 70 mg/dL, glycemic risk assessment diabetes equation hypoglycemia, Low Blood Glucose Index), and hyperglycemia (time spent above 180 mg/dL at night [TSA > 180], AUC above 180 mg/dL [AUC > 180], glycemic risk assessment diabetes equation hyperglycemia, High Blood Glucose Index [HBGI], and J index). The correlation of GV indices with HbA1c, duration of diabetes, and demographic and biochemical parameters were also assessed.
Results: All the CGM-derived measures of GV (SD, MAGE, CONGA, MODD, and %CV), except M value, were significantly higher in the FCPD group than in the T2D group (P < 0.05). Measures of hyperglycemia (TSA >180, AUC >180, HBGI, and J index) were significantly higher in the FCPD group than in the T2D group (P < 0.05). The measures of hypoglycemia were not significantly different between the two groups. All the hyperglycemia indices showed a positive correlation with HbA1c in both groups.
Conclusions: FCPD is associated with higher GV than is T2D. The findings of higher postprandial glycemic excursions in patients with FCPD could have potential therapeutic implications.
Keywords: CGM; MAGE; fibrocalculous pancreatic diabetes; glycemic variability; hypoglycemia; type 2 diabetes.
Patterns of Glycemic Variability During a Diabetes Self-Management Educational Program.Med Sci (Basel). 2019 Mar 25;7(3):52. doi: 10.3390/medsci7030052. Med Sci (Basel). 2019. PMID: 30934620 Free PMC article.
Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.Diabetes Technol Ther. 2016 Dec;18(12):806-812. doi: 10.1089/dia.2016.0146. Diabetes Technol Ther. 2016. PMID: 27996321
Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.Pediatr Diabetes. 2017 Nov;18(7):629-636. doi: 10.1111/pedi.12475. Epub 2016 Nov 22. Pediatr Diabetes. 2017. PMID: 27873436 Free PMC article.
Role of continuous glucose monitoring for type 2 in diabetes management and research.J Diabetes Complications. 2017 Jan;31(1):280-287. doi: 10.1016/j.jdiacomp.2016.10.007. Epub 2016 Oct 14. J Diabetes Complications. 2017. PMID: 27818105 Review.
Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literature.J Diabetes Sci Technol. 2014 Sep;8(5):1042-7. doi: 10.1177/1932296814537039. Epub 2014 May 29. J Diabetes Sci Technol. 2014. PMID: 24876453 Free PMC article. Review.